Navigating the hurdles: Parents' experiences of Elexacaftor/Tezacaftor/Ivacaftor during the early phase of treatment in young children with CF

Objective CFTR modulator therapy has changed the landscape of Cystic Fibrosis care with reports of improved quality of life and physiological markers for adults and adolescents with Cystic Fibrosis (CF), however little is known about the lived experience of caregivers. This study explored parents’ experiences of initiating elexacaftor/tezacaftor/ivacaftor (ETI) in young children with CF in the United Kingdom. Method Three focus groups facilitated by a topic guide were conducted with parents via Microsoft Teams. The focus groups were recorded and transcribed, and thematic analysis was used to identify the main themes. Results Thirteen participants (10 mothers and three fathers) participated. Four main themes were identified: (1) Navigating the hurdles; The feeling of parental responsibility when starting a new medication (2) “It's just one giant guessing game: Is it the medication, or is it my child?” (3) “It is a payoff” benefit observed outweighing the potential side effects for parents (4) Beyond the clinical trials; the practicalities of caring for a young child on ETI. Discussion Starting a new medication is a considered, balanced decision for families, with significant parental responsibility felt emotionally and practically. Clinical teams must work collaboratively with families to support decision-making and monitor young children while introducing new therapies.

Authors

Institutions

Publication Details

Journal
Chronic Illness
Published
2026-11-14
DOI
https://doi.org/10.1177/17423953261491386
Primary Topic
Cystic Fibrosis Research Advances
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Navigating the hurdles: Parents' experiences of Elexacaftor/Tezacaftor/Ivacaftor during the early phase of treatment in young children with CF

Simon Curran, Cliona J. McRobert, Sioned Davies, Adam Walsh et al.
Chronic Illness
Cystic Fibrosis Research Advances
article

Navigating the hurdles: Parents' experiences of Elexacaftor/Tezacaftor/Ivacaftor during the early phase of treatment in young children with CF

Simon Curran, Cliona J. McRobert, Sioned Davies, Adam Walsh, Annabel Taylor, Heather Fogg, Kevin W Southern
article en

Abstract

Objective CFTR modulator therapy has changed the landscape of Cystic Fibrosis care with reports of improved quality of life and physiological markers for adults and adolescents with Cystic Fibrosis (CF), however little is known about the lived experience of caregivers. This study explored parents’ experiences of initiating elexacaftor/tezacaftor/ivacaftor (ETI) in young children with CF in the United Kingdom. Method Three focus groups facilitated by a topic guide were conducted with parents via Microsoft Teams. The focus groups were recorded and transcribed, and thematic analysis was used to identify the main themes. Results Thirteen participants (10 mothers and three fathers) participated. Four main themes were identified: (1) Navigating the hurdles; The feeling of parental responsibility when starting a new medication (2) “It's just one giant guessing game: Is it the medication, or is it my child?” (3) “It is a payoff” benefit observed outweighing the potential side effects for parents (4) Beyond the clinical trials; the practicalities of caring for a young child on ETI. Discussion Starting a new medication is a considered, balanced decision for families, with significant parental responsibility felt emotionally and practically. Clinical teams must work collaboratively with families to support decision-making and monitor young children while introducing new therapies.

Chronic Illness
University of Liverpool (GB), Alder Hey Children's NHS Foundation Trust (GB)
Cystic Fibrosis Research Advances
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon